We focus our research efforts on identifying and developing new and differentiated therapies for pet patients with chronic conditions.

​

Our experienced team identifies and develops pipeline candidates by targeting relevant advances in disease pathogenesis. We also partner with leading academic institutions and other companies that are actively engaged in advancing science that can be leveraged for pet health.

​